Skip to main content
. 2018 Apr 18;2018:8926598. doi: 10.1155/2018/8926598

Table 3.

Tumor response for different doses of doxorubicin monotherapy.

Best overall response Doxorubicin ≧ 75 mg/m2 (n = 16), no. (%) Doxorubicin < 75 mg/m2 (n = 22), no. (%)
Complete response 0 (0) 0 (0)
Partial response 2 (13) 2 (6)
Overall response 2 (13) 2 (6)
Stable disease 5 (31) 14 (44)
Progressive disease 8 (50) 6 (19)
Not evaluable or not assessed 1 (6) 0 (0)